Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASPI
ASPI logo

ASPI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ASP Isotopes Inc (ASPI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
6.710
1 Day change
-15.81%
52 Week Range
14.490
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ASPI is not a strong buy right now for a Beginner with a long-term focus and $50,000-$100,000 to invest. Based on the available data, there is no confirmed technical trend, no valuation support, no positive proprietary signal, and no recent catalyst evidence strong enough to justify an immediate purchase. Since the investor is impatient and does not want to wait for an ideal entry, the clearest action is to hold off and avoid initiating a position at this time.

Technical Analysis

Technical analysis is limited because the stock trend data could not be fetched. With no trend, no support/resistance, and no momentum confirmation available, there is no evidence of an established uptrend or a favorable breakout setup. The only visible market context is that ASPI is moving with the S&P 500 at 0% change, which does not provide a meaningful edge. Overall, the technical picture is inconclusive and does not support a confident buy decision.

Positive Catalysts

  • No recent congress trading data available. No analyst upgrades or price target revisions were provided. No insider or political buying activity was reported in the supplied data. No clear event-driven bullish catalyst was identified from the available information.

Neutral/Negative Catalysts

  • No valuation data is available, stock trend data failed to load, and both Intellectia proprietary signals are absent. There is also no recent congress trading activity, no options-based sentiment to support a bullish read, and no supplied news summary indicating a favorable catalyst. The lack of actionable data itself is a negative factor for a beginner long-term investor seeking confidence in an entry.

Financial Performance

No financial data was provided, so the latest quarter season and growth trends cannot be assessed from the supplied information.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no recent Wall Street consensus trend to review. Based on the missing coverage and lack of visible bullish revisions, Wall Street pros and cons cannot be meaningfully tilted in favor of a buy.

Wall Street analysts forecast ASPI stock price to rise
2 Analyst Rating
Wall Street analysts forecast ASPI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.970
sliders
Low
11
Averages
12
High
13
Current: 7.970
sliders
Low
11
Averages
12
High
13
Cantor Fitzgerald
Derek Soderberg
Overweight
initiated
$13
AI Analysis
2025-12-04
Reason
Cantor Fitzgerald
Derek Soderberg
Price Target
$13
AI Analysis
2025-12-04
initiated
Overweight
Reason
Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes (ASPI) with an Overweight rating and $13 price target. ASP Isotopes has developed advanced isotope-enrichment technology that produces high-value nuclear fuel, medical isotopes, and silicon-28, and currently stands as the sole commercial-scale provider of certain isotopes, the analyst tells investors in a research note. The pending acquisition of Renergen (RGNNF) could give ASPI control of the world's largest high-concentration helium deposit, while the planned spinout of its quantum laser enrichment technology represents a near-term value-creation opportunity, Cantor says.
Cantor Fitzgerald
Derek Soderberg
initiated
$13
2025-12-04
Reason
Cantor Fitzgerald
Derek Soderberg
Price Target
$13
2025-12-04
initiated
Reason
Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes with an Overweight rating and $13 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASPI
Unlock Now

People Also Watch